Related Articles Even Market-Neutral Funds Couldn’t Escape the AI Slump in October It’s Biopharma or Bust for the IPO Market Stephen Taub The Trillion-Dollar Question: How Much Value Must AI Create to Pay for Its Build-Out? Sponsored by Schroders